Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (81-90 of 522) with videos related to

Pageof 53
Sort By:
European Urology|August 24, 2014
Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60Eric A Klein, Matthew R Cooperberg, Peter R Carroll
JAMA Oncology|May 12, 2017
Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?Mary K Downer, Meir J Stampfer, Matthew R Cooperberg
European Urology|September 13, 2016
The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting StudiesJonathan S Brajtbord, Michael S Leapman, Matthew R Cooperberg
BJU International|August 18, 2009
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized diseaseSima P Porten, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|May 19, 2010
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized diseaseAdam C Reese, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|July 11, 2003
Health related quality of life significance of single pad urinary incontinence following radical prostatectomyMatthew R Cooperberg, Viraj A Master, Peter R Carroll
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?Peter R Carroll, Jared M Whitson, Matthew R Cooperberg
European Urology|October 24, 2022
Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than HarmAndrew J Vickers, Matthew R Cooperberg, Scott E Eggener
Journal of the National Cancer Institute|June 11, 2009
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosisMatthew R Cooperberg, Jeanette M Broering, Peter R Carroll
Urologic Oncology|July 4, 2009
Defining high quality health careMatthew R Cooperberg, John D Birkmeyer, Mark S Litwin
Pageof 53

Showing results (81-90 of 522) with videos related to

Sort By:
Pageof 53
European Urology|August 24, 2014
Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60Eric A Klein, Matthew R Cooperberg, Peter R Carroll
JAMA Oncology|May 12, 2017
Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?Mary K Downer, Meir J Stampfer, Matthew R Cooperberg
European Urology|September 13, 2016
The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting StudiesJonathan S Brajtbord, Michael S Leapman, Matthew R Cooperberg
BJU International|August 18, 2009
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized diseaseSima P Porten, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|May 19, 2010
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized diseaseAdam C Reese, Matthew R Cooperberg, Peter R Carroll
The Journal of Urology|July 11, 2003
Health related quality of life significance of single pad urinary incontinence following radical prostatectomyMatthew R Cooperberg, Viraj A Master, Peter R Carroll
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?Peter R Carroll, Jared M Whitson, Matthew R Cooperberg
European Urology|October 24, 2022
Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than HarmAndrew J Vickers, Matthew R Cooperberg, Scott E Eggener
Journal of the National Cancer Institute|June 11, 2009
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosisMatthew R Cooperberg, Jeanette M Broering, Peter R Carroll
Urologic Oncology|July 4, 2009
Defining high quality health careMatthew R Cooperberg, John D Birkmeyer, Mark S Litwin
Pageof 53